• Tarek Madni
  • Alexander L. Eastman


According to the Centers for Disease Control and Prevention (CDC), central line-associated bloodstream infections (CLABSIs) result in thousands of deaths and add billions of dollars of burden to the United States (US) healthcare system each year. CLABSIs have an estimated mortality rate of 12–25% and are thought to be one of the deadliest types of healthcare-associated infections (HAIs). Following catheter-associated urinary tract infections, CLABSIs are estimated to be the second most preventable HAI and have been estimated to be as high as the eighth leading cause of death in the United States. In recent years, the Centers for Medicare and Medicaid Services developed a policy to both deny hospital payments for treatment of hospital-acquired preventable events and potentially impose financially penalties. Through a number of preventative measures, the rate of CLABSI has significantly declined over the past decade, with roughly 18,000 reported occurrences among patients hospitalized in intensive care units (ICUs) in the United States in 2009.


Central line-associated bloodstream infections CLABSI Central lines Catheter-related bloodstream infection CRBSI Catheter 


  1. 1.
    Center for Disease Control and Prevention. Central Line-associated Bloodstream Infection (CLABSI) 2016 updated 3/1/2016. Available from:
  2. 2.
    Center for Disease Control and Prevention. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011;60(8):243–8.Google Scholar
  3. 3.
    Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101–14.CrossRefGoogle Scholar
  4. 4.
    Miller SE, Maragakis LL. Central line-associated bloodstream infection prevention. Curr Opin Infect Dis. 2012;25(4):412–22.CrossRefGoogle Scholar
  5. 5.
    Clancy CM. CMS’s hospital-acquired condition lists link hospital payment, patient safety. Am J Med Qual. 2009;24(2):166–8.CrossRefGoogle Scholar
  6. 6.
    The Joint Commission. CLABSI Toolkit – Preventing Central-Line Associated Bloodstream Infections: Useful Tools, An International Perspective 2017 updated 2017. Available from:
  7. 7.
    O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4 Suppl 1):S1–34.CrossRefGoogle Scholar
  8. 8.
    Ramritu P, Halton K, Cook D, Whitby M, Graves N. Catheter-related bloodstream infections in intensive care units: a systematic review with meta-analysis. J Adv Nurs. 2008;62(1):3–21.CrossRefGoogle Scholar
  9. 9.
    Galpern D, Guerrero A, Tu A, Fahoum B, Wise L. Effectiveness of a central line bundle campaign on line-associated infections in the intensive care unit. Surgery. 2008;144(4):492–5; discussion 5.CrossRefGoogle Scholar
  10. 10.
    Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–32.CrossRefGoogle Scholar
  11. 11.
    Guerin K, Wagner J, Rains K, Bessesen M. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control. 2010;38(6):430–3.CrossRefGoogle Scholar
  12. 12.
    Lai NM, Lai NA, O’Riordan E, Chaiyakunapruk N, Taylor JE, Tan K. Skin antisepsis for reducing central venous catheter-related infections. Cochrane Database Syst Rev. 2016;(7):Cd010140.Google Scholar
  13. 13.
    Gavin NC, Webster J, Chan RJ, Rickard CM. Frequency of dressing changes for central venous access devices on catheter-related infections. Cochrane Database Syst Rev. 2016;(2):Cd009213.Google Scholar
  14. 14.
    Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WS, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev. 2016;(3):Cd007878.Google Scholar
  15. 15.
    Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM. Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev. 2015;(9):Cd010367.Google Scholar
  16. 16.
    Shah HN, Schwartz JL, Luna G, Cullen DL. Bathing with 2% chlorhexidine gluconate: evidence and costs associated with central line-associated bloodstream infections. Crit Care Nurs Q. 2016;39(1):42–50.CrossRefGoogle Scholar
  17. 17.
    O’Horo JC, Silva GL, Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol. 2012;33(3):257–67.CrossRefGoogle Scholar
  18. 18.
    Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011.CrossRefGoogle Scholar
  19. 19.
    Soe MM, Edwards JR, Sievert DM, Ricks PM, Magill SS, Fridkin SK. Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011. Infect Control Hosp Epidemiol. 2015;36(1):54–64.CrossRefGoogle Scholar
  20. 20.
    Duane TM, Kikhia RM, Wolfe LG, Ober J, Tessier JM. Understanding gram-negative central line-associated blood stream infection in a surgical trauma ICU. Am Surg. 2015;81(8):816–9.PubMedGoogle Scholar
  21. 21.
    See I, Freifeld AG, Magill SS. Causative organisms and associated antimicrobial resistance in healthcare-associated, central line-associated bloodstream infections from oncology settings, 2009–2012. Clin Infect Dis. 2016;62(10):1203–9.CrossRefGoogle Scholar
  22. 22.
    Fagan RP, Edwards JR, Park BJ, Fridkin SK, Magill SS. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990–2010. Infect Control Hosp Epidemiol. 2013;34(9):893–9.CrossRefGoogle Scholar
  23. 23.
    Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. JAMA. 2009;301(7):727–36.CrossRefGoogle Scholar
  24. 24.
    Chatzinikolaou I, Hanna H, Hachem R, Alakech B, Tarrand J, Raad I. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis. 2004;50(3):167–72.CrossRefGoogle Scholar
  25. 25.
    Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.CrossRefGoogle Scholar
  26. 26.
    Everts RJ, Vinson EN, Adholla PO, Reller LB. Contamination of catheter-drawn blood cultures. J Clin Microbiol. 2001;39(9):3393–4.CrossRefGoogle Scholar
  27. 27.
    Rijnders BJ, Peetermans WE, Verwaest C, Wilmer A, Van Wijngaerden E. Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med. 2004;30(6):1073–80.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Surgery, Division of Burns, Trauma, and Critical CareUniversity of Texas SouthwesternDallasUSA

Personalised recommendations